Mesenchymal stem cells have been used for cardiovascular regenerative therapy for
decades. These cells have been established as one of the potential therapeutic agents …

Some of the most significant leaps in the history of modern civilization—the development of
article in China, the steam engine, which led to the European industrial revolution, and the …

Aims Comparative studies suggest that stem cells committed to a cardiac lineage are more
effective for improving heart function than those featuring an extra-cardiac phenotype. We …

Today, a wide variety of bio-and nanomaterials have been deployed for cardiovascular
tissue engineering (TE), including polymers, metal oxides, graphene/its derivatives …

Progress in the understanding of the biology of perinatal tissues has contributed to the
breakthrough revelation of the therapeutic effects of perinatal derivatives (PnD), namely birth …

Aim There is now compelling evidence that cells committed to a cardiac lineage are most
effective for improving the function of infarcted hearts. This has been confirmed by our pre …

Despite considerable improvements in the treatment of cardiovascular diseases, heart
failure (HF) still represents one of the leading causes of death worldwide. Poor prognosis is …

Fibrin is a topical haemostat, sealant and tissue glue, which consists of concentrated
fibrinogen and thrombin. It has broad medical and research uses. Recently, several studies …

Intense scientific research over the past two decades has yielded much knowledge about
embryonic stem cells, mesenchymal stem cells from bone marrow, as well as epithelial stem …

Doxorubicin (dox) is an effective chemotherapeutic agent that leads to cardiotoxicity. An
alternative treatment for dox-cardiotoxicity is autologous mesenchymal stem cells (MSCs) …